SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-149556
Filing Date
2021-12-14
Accepted
2021-12-14 16:05:55
Documents
14
Period of Report
2021-12-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2135434d1_8k.htm   iXBRL 8-K 28764
2 EXHIBIT 99.1 tm2135434d1_ex99-1.htm EX-99.1 15293
3 EXHIBIT 99.2 tm2135434d1_ex99-2.htm EX-99.2 16780
  Complete submission text file 0001104659-21-149556.txt   243588

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA clrb-20211208.xsd EX-101.SCH 3028
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE clrb-20211208_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clrb-20211208_pre.xml EX-101.PRE 22361
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2135434d1_8k_htm.xml XML 3482
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36598 | Film No.: 211491043
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences